Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.Biomarker correlation network in colorectal carcinoma by tumor anatomic location.Prognostic value of high IMP3 expression in solid tumors: a meta-analysisUsing immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese casesIMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stageAn isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinomaThe RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical studyFuture directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyIMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis.Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization.mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa.IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia.IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer.Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.Genomics, Telomere Length, Epigenetics, and Metabolomics in the Nurses' Health Studies.IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
P2860
Q24289344-805039A4-6D03-47DD-94A0-442E1A9291A0Q30978083-11E56853-FFB3-42B3-B6F4-B430D96B85FEQ33274978-85DAE6B9-C7D8-4323-BF34-E61F9B665A4DQ33808553-CD56AD03-18C8-4BA3-8C3B-FD73B9CAF135Q33813288-71D142A0-70B0-48B5-9E2F-5D20C201CDF9Q33895858-13B81ABD-4957-4D43-9A92-BCE214EB9491Q35863071-00941FAD-71F7-432E-94F8-E7747626D14CQ35909674-0F83B530-CA8C-4443-8E2E-40F16DDB71AAQ35993153-5A998BCE-D310-4F7B-AE17-A596BB359A4FQ36261604-15654AD5-158D-47E9-82E1-801F43E5D439Q36413135-28C78E67-0275-4BEC-9768-F12261EA7699Q36723387-22152588-5301-4529-BD82-C9716774CF6BQ36931876-B533D0F9-D17F-4909-AD63-95104140BE3CQ37106318-0A37040F-9039-40A1-9023-490219D02452Q37262152-0A9832ED-AB4B-4D91-A1EF-68CBE9882169Q37747546-144281D5-E963-4EAB-9A47-C6891096F8E2Q39133014-7EDBD094-17C6-452B-B04A-9AE5D8983ECCQ41136311-123D6D53-287B-48A9-B2EB-6F996043D8BCQ41136544-B6BB0304-C7C9-4D69-9656-690C80830627Q41283886-4D41125B-5611-4558-BDE0-D6B6EC4B2A64Q42083354-21AA5CDC-4A50-4EC7-ACB0-166EE4DC24B2Q42318105-410BB6B5-A6D6-445D-B55C-7481659D8D74Q47135760-2007F385-23EE-433E-9531-AF077C7ACE9AQ47426765-46A460AA-CCF5-418B-A3B7-B8FA36F6E98BQ49187441-0A381FAA-881E-4F12-A4E4-06CEC5261833Q52800577-BC12A7F8-C570-4164-8502-AEB52F89782FQ52858262-1A48968C-D05F-4E1C-B0DA-71D05E54BDBFQ53351079-7A7F552B-ACDD-4B64-9CEE-94C53584C1A8Q54217314-297AE223-6926-4835-9218-3C7A8571DC38
P2860
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@ast
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@en
type
label
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@ast
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@en
prefLabel
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@ast
Insulin-like growth factor 2 m ...... rognosis in colorectal cancer.
@en
P2093
P2860
P50
P1476
Insulin-like growth factor 2 m ...... prognosis in colorectal cancer
@en
P2093
Aya Kuchiba
Mai Yamauchi
Paul Lochhead
Reiko Nishihara
Teppei Morikawa
Xiaoyun Liao
Yu Imamura
P2860
P304
P356
10.1016/J.EJCA.2012.06.021
P577
2012-07-26T00:00:00Z